carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - myeloma multiplex - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
cernevit por oldatos injekcióhoz vagy infúzióhoz
baxter (hungary) kft. - vitaminok -
vitamin b12 rph pharmaceuticals 1 mg/ml oldatos injekció
rph ab - hidroxokobalaminnal -
nipruss 60 mg por oldatos infúzióhoz
altamedics gmbh - a nátrium nitroprusszid -
polyvitaplex 8 filmtabletta
sanofi-aventis zrt. - vitaminok -
b12-vitamin ankermann 1000 mikrogramm bevont tabletta
wörwag pharma gmbh&co.kg - cianokobalamin -
nocutil 0,1 mg tabletta
gebro pharma gmbh - desmopressin -
nocutil 0,2 mg tabletta
gebro pharma gmbh - desmopressin -
nocutil 0,1 mg/ml oldatos orrspray
gebro pharma gmbh - desmopressin -
tisseel lyo por és oldószer szövetragasztóhoz
baxter (hungary) kft. - humán fibrinogén; trombin; aprotinin; kalcium-klorid - local hemostatics